Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ko Yamamoto

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|December 23, 2022
Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysisJohny Nicolas, George Dangas, Mauro Chiarito, et al.
Circulation Reports|September 12, 2024
Impact of Cognitive Impairment on Long-Term Outcomes After Transcatheter Aortic Valve ImplantationNorihisa Miyawaki, Kenichi Ishizu, Shinichi Shirai, et al.
American Heart Journal|June 14, 2024
Impact of the clinical frailty scale on long-term outcomes after transcatheter aortic valve implantationNorihisa Miyawaki, Kenichi Ishizu, Shinichi Shirai, et al.
Journal of Cardiology|January 16, 2025
Association between delirium severity and prognosis following Transcatheter aortic valve implantationTomohiro Suenaga, Kenichi Ishizu, Shinichi Shirai, et al.
The American Journal of Cardiology|May 13, 2024
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease and DiabetesKo Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
Journal of Cardiology|December 22, 2023
Effects of peripheral artery disease on long-term outcomes after percutaneous coronary intervention versus coronary artery bypass grafting in patients with severe coronary artery diseaseRyusuke Nishikawa, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 7, 2020
Effects of Body Weight on Bleeding and Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-2Ko Yamamoto, Masahiro Natsuaki, Yusuke Yoshikawa, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 29, 2024
Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trialYuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, et al.
JACC. Cardiovascular Interventions|June 5, 2025
Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment ElevationYuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, et al.
Circulation Reports|April 11, 2025
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease and Left Ventricular DysfunctionKo Yamamoto, Hiroki Shiomi, Ryusuke Nishikawa, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
European Heart Journal. Cardiovascular Pharmacotherapy|December 23, 2022
Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysisJohny Nicolas, George Dangas, Mauro Chiarito, et al.
Circulation Reports|September 12, 2024
Impact of Cognitive Impairment on Long-Term Outcomes After Transcatheter Aortic Valve ImplantationNorihisa Miyawaki, Kenichi Ishizu, Shinichi Shirai, et al.
American Heart Journal|June 14, 2024
Impact of the clinical frailty scale on long-term outcomes after transcatheter aortic valve implantationNorihisa Miyawaki, Kenichi Ishizu, Shinichi Shirai, et al.
Journal of Cardiology|January 16, 2025
Association between delirium severity and prognosis following Transcatheter aortic valve implantationTomohiro Suenaga, Kenichi Ishizu, Shinichi Shirai, et al.
The American Journal of Cardiology|May 13, 2024
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease and DiabetesKo Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
Journal of Cardiology|December 22, 2023
Effects of peripheral artery disease on long-term outcomes after percutaneous coronary intervention versus coronary artery bypass grafting in patients with severe coronary artery diseaseRyusuke Nishikawa, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 7, 2020
Effects of Body Weight on Bleeding and Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-2Ko Yamamoto, Masahiro Natsuaki, Yusuke Yoshikawa, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 29, 2024
Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trialYuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, et al.
JACC. Cardiovascular Interventions|June 5, 2025
Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment ElevationYuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, et al.
Circulation Reports|April 11, 2025
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease and Left Ventricular DysfunctionKo Yamamoto, Hiroki Shiomi, Ryusuke Nishikawa, et al.
Pageof 10